BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12035842)

  • 1. Ifosfamide encephalopathy and nonconvulsive status epilepticus.
    Primavera A; Audenino D; Cocito L
    Can J Neurol Sci; 2002 May; 29(2):180-3. PubMed ID: 12035842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonconvulsive status epilepticus due to ifosfamide.
    Kilickap S; Cakar M; Onal IK; Tufan A; Akoglu H; Aksoy S; Erman M; Tekuzman G
    Ann Pharmacother; 2006 Feb; 40(2):332-5. PubMed ID: 16449538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ifosfamide induced encephalopathy: 15 observations].
    Dufour C; Grill J; Sabouraud P; Behar C; Munzer M; Motte J; Oberlin O; Paci A; Hartmann O
    Arch Pediatr; 2006 Feb; 13(2):140-5. PubMed ID: 16364615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ifosfamide chemotherapy and nonconvulsive status epilepticus: case report and review of the literature.
    Taupin D; Racela R; Friedman D
    Clin EEG Neurosci; 2014 Jul; 45(3):222-5. PubMed ID: 24151171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of thiamine in managing ifosfamide-induced encephalopathy.
    Hamadani M; Awan F
    J Oncol Pharm Pract; 2006 Dec; 12(4):237-9. PubMed ID: 17156595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ifosfamide related encephalopathy: the need for a timely EEG evaluation.
    Feyissa AM; Tummala S
    J Neurol Sci; 2014 Jan; 336(1-2):109-12. PubMed ID: 24209900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifosfamide neuropsychiatric toxicity in patients with cancer.
    Alici-Evcimen Y; Breitbart WS
    Psychooncology; 2007 Oct; 16(10):956-60. PubMed ID: 17278152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ifosfamide induced encephalopathy following chemotherapy of Non-Hodgkin's Lymphoma.
    Jain S; Moger V; Kumari S; Varma S
    Neurol India; 2001 Dec; 49(4):416. PubMed ID: 11799423
    [No Abstract]   [Full Text] [Related]  

  • 9. Ifosfamide-induced encephalopathy in patients with uterine sarcoma.
    Liu YL; Tsai SH; Chang FW; Yu MH
    Taiwan J Obstet Gynecol; 2010 Mar; 49(1):77-80. PubMed ID: 20466298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifosfamide neurotoxicity: an atypical presentation with psychiatric manifestations.
    Kerdudo C; Orbach D; Sarradet JL; Doz F
    Pediatr Blood Cancer; 2006 Jul; 47(1):100-2. PubMed ID: 16261598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged postictal stupor: nonconvulsive status epilepticus, medication effect, or postictal state?
    Langheinrich TC; Chattopadhyay A; Kuc S; Reuber M
    Epilepsy Behav; 2005 Nov; 7(3):548-51. PubMed ID: 16194625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxicity during ifosfamide treatment in children.
    Di Cataldo A; Astuto M; Rizzo G; Bertuna G; Russo G; Incorpora G
    Med Sci Monit; 2009 Jan; 15(1):CS22-5. PubMed ID: 19114973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.
    Pelgrims J; De Vos F; Van den Brande J; Schrijvers D; Prové A; Vermorken JB
    Br J Cancer; 2000 Jan; 82(2):291-4. PubMed ID: 10646879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ifosfamide-induced neurotoxicity reversal with continuous veno-venous hemodialysis. A case report.
    Cherry MA; Bhardwaj H; Hopps S; Srour S; Pant S
    J Oncol Pharm Pract; 2013 Sep; 19(3):261-4. PubMed ID: 23135805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of ifosfamide neurotoxicity with dexmedetomidine.
    Bernard PA; McCabe T; Bayliff S; Hayes D
    J Oncol Pharm Pract; 2010 Dec; 16(4):262-5. PubMed ID: 20118215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and EEG Characteristics of Ifosfamide-Related Encephalopathy.
    Gusdon AM; Malani R; Chen X
    J Clin Neurophysiol; 2019 Mar; 36(2):150-154. PubMed ID: 30694943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonconvulsive status epilepticus during childhood: clinical and electroencephalographic features.
    Yilmaz Y; Onultan O; Berber M
    Turk J Pediatr; 2008; 50(5):449-55. PubMed ID: 19102049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe ifosfamide-induced neurotoxicity: a case report.
    Ramos Linares S; Breña Atienza J; Cháfer Rudilla M; Ríos Rull P; Cabello Rodríguez A; Merino Alonso J
    Pharm World Sci; 2010 Apr; 32(2):109-11. PubMed ID: 20033290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ifosfamide causes a diazepam-sensitive encephalopathy.
    Simonian NA; Gilliam FG; Chiappa KH
    Neurology; 1993 Dec; 43(12):2700-2. PubMed ID: 8255482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.